<!DOCTYPE html>
<html lang="en" data-arca>
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Ulcerative Colitis BRA â€” ArcaScience | JAK Inhibitors, Anti-TNF &amp; S1P Modulators</title>
  <meta name="description" content="AI-driven benefit-risk analysis for Ulcerative Colitis covering JAK inhibitors (tofacitinib, upadacitinib), anti-TNF (infliximab, golimumab), S1P modulators (ozanimod), vedolizumab, and mirikizumab. ArcaScience models MACE/VTE risk, infection profiles, and colectomy as a safety endpoint.">

  <link rel="preload" href="/fonts/Inter-Variable.woff2" as="font" type="font/woff2" crossorigin>
  <link rel="preload" href="/fonts/Literata-Variable.woff2" as="font" type="font/woff2" crossorigin>
  <link rel="stylesheet" href="/dist/arcascience-global.min.css">

  <script>
    (function(){
      if(window.matchMedia&&window.matchMedia('(prefers-reduced-motion: reduce)').matches){
        document.documentElement.classList.add('reduced-motion');
      }
    })();
  </script>
</head>
<body>

  <div data-scroll-progress></div>

  <!-- NAVIGATION -->
  <nav class="arca-nav" data-nav="sticky" role="navigation" aria-label="Main navigation">
    <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px; display: flex; align-items: center; justify-content: space-between; height: 100%;">
      <a href="/" aria-label="ArcaScience home">
        <img src="/images/arcascience-logo.svg" alt="ArcaScience" height="32">
      </a>
      <div style="display: flex; align-items: center; gap: 32px;">
        <a href="/" class="arca-nav-link">Home</a>
        <div style="position: relative;" class="arca-nav-dropdown-wrap">
          <a href="/platform-overview" class="arca-nav-link">Platform <svg width="10" height="6" viewBox="0 0 10 6" fill="none" style="margin-left: 4px; vertical-align: middle;"><path d="M1 1L5 5L9 1" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></a>
          <div class="arca-nav-dropdown" style="position: absolute; top: 100%; left: -12px; min-width: 260px; padding: 8px 0; background: rgba(255,255,255,0.97); backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px); border: 1px solid rgba(209,213,222,0.5); border-radius: 12px; box-shadow: 0 4px 12px rgba(0,0,0,0.06), 0 12px 32px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-8px); transition: opacity 200ms ease, transform 200ms ease, visibility 200ms; z-index: 100;">
            <a href="/platform-overview" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Platform Overview</a>
            <a href="/platform-how-it-works" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">How It Works</a>
            <a href="/platform-data-intelligence" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Data Intelligence</a>
            <a href="/platform-ai-models" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">AI Models</a>
            <a href="/platform-outputs" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Regulatory Outputs</a>
            <a href="/platform-integrations" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Integrations</a>
            <div style="height: 1px; background: linear-gradient(90deg, transparent, rgba(35,86,160,0.15), transparent); margin: 6px 12px;"></div>
            <a href="/security-compliance" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Security &amp; Compliance</a>
          </div>
        </div>
        <div style="position: relative;" class="arca-nav-dropdown-wrap">
          <a href="/solution-therapeutic-area" class="arca-nav-link is-active">Solutions <svg width="10" height="6" viewBox="0 0 10 6" fill="none" style="margin-left: 4px; vertical-align: middle;"><path d="M1 1L5 5L9 1" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></a>
          <div class="arca-nav-dropdown" style="position: absolute; top: 100%; left: -12px; min-width: 260px; padding: 8px 0; background: rgba(255,255,255,0.97); backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px); border: 1px solid rgba(209,213,222,0.5); border-radius: 12px; box-shadow: 0 4px 12px rgba(0,0,0,0.06), 0 12px 32px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-8px); transition: opacity 200ms ease, transform 200ms ease, visibility 200ms; z-index: 100;">
            <p style="padding: 6px 16px 4px; font-size: 0.6875rem; font-weight: 600; letter-spacing: 0.08em; text-transform: uppercase; color: var(--grey-400); margin: 0;">By Approach</p>
            <a href="/solution-therapeutic-area" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">By Therapeutic Area</a>
            <a href="/solution-lifecycle-phase" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">By Lifecycle Phase</a>
            <a href="/solution-role" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">By Role</a>
            <div style="height: 1px; background: linear-gradient(90deg, transparent, rgba(35,86,160,0.15), transparent); margin: 6px 12px;"></div>
            <p style="padding: 6px 16px 4px; font-size: 0.6875rem; font-weight: 600; letter-spacing: 0.08em; text-transform: uppercase; color: var(--grey-400); margin: 0;">By Stage</p>
            <a href="/solution-early-development" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Early Development</a>
            <a href="/solution-late-development" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Late Development</a>
            <a href="/solution-post-marketing" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Post-Marketing</a>
            <a href="/solution-market-access" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Market Access</a>
            <div style="height: 1px; background: linear-gradient(90deg, transparent, rgba(35,86,160,0.15), transparent); margin: 6px 12px;"></div>
            <p style="padding: 6px 16px 4px; font-size: 0.6875rem; font-weight: 600; letter-spacing: 0.08em; text-transform: uppercase; color: var(--grey-400); margin: 0;">Therapeutic Areas</p>
            <a href="/ta-oncology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Oncology</a>
            <a href="/disease-breast-cancer" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Breast Cancer</a>
            <a href="/disease-melanoma" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Melanoma</a>
            <a href="/disease-nsclc" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">NSCLC</a>
            <a href="/disease-aml" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">AML</a>
            <a href="/ta-neurology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Neurology</a>
            <a href="/disease-alzheimers" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Alzheimer's</a>
            <a href="/disease-parkinsons" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Parkinson's</a>
            <a href="/disease-multiple-sclerosis" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Multiple Sclerosis</a>
            <a href="/disease-sma" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">SMA</a>
            <a href="/ta-immunology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Immunology</a>
            <a href="/disease-rheumatoid-arthritis" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Rheumatoid Arthritis</a>
            <a href="/disease-psoriasis" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Psoriasis</a>
            <a href="/disease-lupus" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Lupus</a>
            <a href="/ta-cardiology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Cardiology</a>
            <a href="/disease-afib" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">AFib</a>
            <a href="/disease-heart-failure" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Heart Failure</a>
            <a href="/ta-respiratory" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Respiratory</a>
            <a href="/disease-asthma" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Asthma</a>
            <a href="/disease-cystic-fibrosis" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Cystic Fibrosis</a>
            <a href="/ta-rare-diseases" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Rare Diseases</a>
            <a href="/disease-sma" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">SMA</a>
            <a href="/disease-cystic-fibrosis" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Cystic Fibrosis</a>
            <a href="/ta-dermatology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Dermatology</a>
            <a href="/disease-atopic-dermatitis" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Atopic Dermatitis</a>
            <a href="/ta-hematology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Hematology</a>
            <a href="/disease-multiple-myeloma" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Multiple Myeloma</a>
            <a href="/ta-gastroenterology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Gastroenterology</a>
            <a href="/disease-crohns-disease" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Crohn's Disease</a>
            <a href="/disease-ulcerative-colitis" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Ulcerative Colitis</a>
            <a href="/ta-endocrinology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Endocrinology</a>
            <a href="/disease-type-2-diabetes" style="display: block; padding: 4px 16px 4px 28px; font-size: 0.75rem; color: var(--grey-500); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Type 2 Diabetes</a>
            <a href="/ta-infectious-disease" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Infectious Disease</a>
            <a href="/ta-pediatrics" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Pediatrics</a>
          </div>
        </div>
        <div style="position: relative;" class="arca-nav-dropdown-wrap">
          <a href="/evidence-case-studies-hub" class="arca-nav-link">Evidence <svg width="10" height="6" viewBox="0 0 10 6" fill="none" style="margin-left: 4px; vertical-align: middle;"><path d="M1 1L5 5L9 1" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></a>
          <div class="arca-nav-dropdown" style="position: absolute; top: 100%; left: -12px; min-width: 220px; padding: 8px 0; background: rgba(255,255,255,0.97); backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px); border: 1px solid rgba(209,213,222,0.5); border-radius: 12px; box-shadow: 0 4px 12px rgba(0,0,0,0.06), 0 12px 32px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-8px); transition: opacity 200ms ease, transform 200ms ease, visibility 200ms; z-index: 100;">
            <a href="/evidence-case-studies-hub" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Case Studies</a>
            <a href="/evidence-publications" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Publications</a>
            <a href="/evidence-metrics" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Platform Metrics</a>
          </div>
        </div>
        <div style="position: relative;" class="arca-nav-dropdown-wrap">
          <a href="/about" class="arca-nav-link">Company <svg width="10" height="6" viewBox="0 0 10 6" fill="none" style="margin-left: 4px; vertical-align: middle;"><path d="M1 1L5 5L9 1" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></a>
          <div class="arca-nav-dropdown" style="position: absolute; top: 100%; left: -12px; min-width: 200px; padding: 8px 0; background: rgba(255,255,255,0.97); backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px); border: 1px solid rgba(209,213,222,0.5); border-radius: 12px; box-shadow: 0 4px 12px rgba(0,0,0,0.06), 0 12px 32px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-8px); transition: opacity 200ms ease, transform 200ms ease, visibility 200ms; z-index: 100;">
            <a href="/about" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">About ArcaScience</a>
            <a href="/leadership" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Leadership</a>
            <a href="/careers" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Careers</a>
            <a href="/science-methodology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Science &amp; Methodology</a>
          </div>
        </div>
        <div style="position: relative;" class="arca-nav-dropdown-wrap">
          <a href="/resources" class="arca-nav-link">Resources <svg width="10" height="6" viewBox="0 0 10 6" fill="none" style="margin-left: 4px; vertical-align: middle;"><path d="M1 1L5 5L9 1" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></a>
          <div class="arca-nav-dropdown" style="position: absolute; top: 100%; right: -12px; min-width: 220px; padding: 8px 0; background: rgba(255,255,255,0.97); backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px); border: 1px solid rgba(209,213,222,0.5); border-radius: 12px; box-shadow: 0 4px 12px rgba(0,0,0,0.06), 0 12px 32px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-8px); transition: opacity 200ms ease, transform 200ms ease, visibility 200ms; z-index: 100;">
            <a href="/resources" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Resource Hub</a>
            <a href="/resources-whitepapers" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Whitepapers</a>
            <a href="/resources-webinars" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Webinars &amp; Events</a>
            <div style="height: 1px; background: linear-gradient(90deg, transparent, rgba(35,86,160,0.15), transparent); margin: 6px 12px;"></div>
            <a href="/resources-faq" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">FAQ</a>
            <a href="/resources-glossary" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Glossary</a>
          </div>
        </div>
      </div>
      <a href="/contact" class="arca-btn-primary" style="height: 40px; padding: 8px 24px; font-size: 0.875rem;">Talk to a Scientist</a>
    </div>
  </nav>

  <div style="height: var(--nav-height);"></div>

  <main role="main">

    <!-- HERO -->
    <section class="arca-bg-blue-900" style="position: relative; overflow: hidden; padding: var(--space-8) 0 var(--space-9);" data-animate>
      <div style="position: absolute; top: -100px; right: -100px; width: 500px; height: 500px; background: radial-gradient(circle, rgba(13, 148, 136, 0.12) 0%, transparent 70%); border-radius: 50%; filter: blur(60px); pointer-events: none; animation: as-float 8s ease-in-out infinite; z-index: 0;"></div>
      <div style="position: absolute; bottom: -80px; left: -80px; width: 400px; height: 400px; background: radial-gradient(circle, rgba(59, 125, 216, 0.06) 0%, transparent 70%); border-radius: 50%; filter: blur(60px); pointer-events: none; animation: as-float 10s ease-in-out infinite reverse; z-index: 0;"></div>

      <svg width="420" height="320" viewBox="0 0 420 320" fill="none" aria-hidden="true" style="position: absolute; right: -20px; top: 50%; transform: translateY(-50%); opacity: 0.12; pointer-events: none; z-index: 0;">
        <circle cx="210" cy="160" r="16" stroke="rgba(13,148,136,0.5)" stroke-width="1.5" fill="none"/>
        <circle cx="210" cy="160" r="6" fill="rgba(13,148,136,0.3)"/>
        <circle cx="290" cy="100" r="10" stroke="rgba(13,148,136,0.4)" stroke-width="1" fill="none"/>
        <circle cx="130" cy="100" r="10" stroke="rgba(13,148,136,0.4)" stroke-width="1" fill="none"/>
        <circle cx="290" cy="220" r="10" stroke="rgba(13,148,136,0.4)" stroke-width="1" fill="none"/>
        <circle cx="130" cy="220" r="10" stroke="rgba(13,148,136,0.4)" stroke-width="1" fill="none"/>
        <line x1="210" y1="160" x2="290" y2="100" stroke="rgba(13,148,136,0.3)" stroke-width="1.5"/>
        <line x1="210" y1="160" x2="130" y2="100" stroke="rgba(13,148,136,0.3)" stroke-width="1.5"/>
        <line x1="210" y1="160" x2="290" y2="220" stroke="rgba(13,148,136,0.3)" stroke-width="1.5"/>
        <line x1="210" y1="160" x2="130" y2="220" stroke="rgba(13,148,136,0.3)" stroke-width="1.5"/>
      </svg>

      <div style="position: relative; z-index: 1; max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <nav aria-label="Breadcrumb" style="margin-bottom: var(--space-5);">
          <ol style="list-style: none; padding: 0; margin: 0; display: flex; align-items: center; gap: 8px; font-size: 0.75rem;">
            <li><a href="/" style="color: rgba(255,255,255,0.65); text-decoration: none;">Home</a></li>
            <li style="color: rgba(255,255,255,0.4);">/</li>
            <li><a href="/solution-therapeutic-area" style="color: rgba(255,255,255,0.65); text-decoration: none;">Therapeutic Areas</a></li>
            <li style="color: rgba(255,255,255,0.4);">/</li>
            <li><a href="/ta-gastroenterology" style="color: rgba(255,255,255,0.65); text-decoration: none;">Gastroenterology</a></li>
            <li style="color: rgba(255,255,255,0.4);">/</li>
            <li style="color: var(--white);">Ulcerative Colitis</li>
          </ol>
        </nav>

        <div style="max-width: 820px;">
          <p data-animate="fade" class="arca-label arca-text-blue-400" style="margin-bottom: var(--space-3);">Gastroenterology &rsaquo; Ulcerative Colitis</p>
          <h1 data-animate="slide-up" data-animate-delay="100" class="arca-display-lg arca-text-white" style="margin-bottom: var(--space-5);">
            AI-Driven Benefit-Risk Analysis for Ulcerative Colitis
          </h1>
          <p data-animate="slide-up" data-animate-delay="200" class="arca-body-lg" style="color: rgba(255,255,255,0.85); max-width: 680px; margin-bottom: var(--space-7);">
            Ulcerative colitis BRA spans JAK inhibitors (tofacitinib, upadacitinib), S1P receptor modulators (ozanimod), gut-selective biologics (vedolizumab), anti-TNF agents (infliximab, golimumab), and anti-IL23 (mirikizumab). ArcaScience delivers mechanism-specific safety profiling across cardiovascular risk, infection susceptibility, and colectomy avoidance modeling.
          </p>
          <div data-animate="slide-up" data-animate-delay="300" style="display: flex; gap: 16px; flex-wrap: wrap;">
            <a href="/platform-overview" class="arca-btn-primary-inverted">See Platform</a>
            <a href="/contact?disease=ulcerative-colitis" class="arca-btn-secondary" style="border-color: rgba(255,255,255,0.3); color: var(--white);">Request Demo</a>
          </div>
        </div>
      </div>
    </section>

    <!-- KEY STATISTICS -->
    <section class="arca-credibility-bar" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="display: grid; grid-template-columns: repeat(4, 1fr); gap: 32px; text-align: center;">
          <div class="arca-credibility-metric">
            <span class="arca-stat-lg" data-countup="5000000" data-countup-suffix="+">5,000,000+</span>
            <p class="arca-caption">UC patients globally</p>
          </div>
          <div class="arca-credibility-metric">
            <span class="arca-stat-lg" data-countup="1600" data-countup-suffix="+">1,600+</span>
            <p class="arca-caption">UC clinical trials analyzed</p>
          </div>
          <div class="arca-credibility-metric">
            <span class="arca-stat-lg" data-countup="10" data-countup-prefix="$" data-countup-suffix="B">$10B</span>
            <p class="arca-caption">Global UC therapeutics market</p>
          </div>
          <div class="arca-credibility-metric">
            <span class="arca-stat-lg" data-countup="7" data-countup-suffix="+">7+</span>
            <p class="arca-caption">Distinct mechanism classes approved for UC</p>
          </div>
        </div>
      </div>
    </section>

    <!-- DISEASE OVERVIEW -->
    <section style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="max-width: 720px; margin: 0 auto 48px; text-align: center;">
          <p class="arca-section-label">Disease Overview</p>
          <h2 class="arca-display-sm" style="margin-bottom: var(--space-5);">Why Ulcerative Colitis Demands Specialized BRA</h2>
          <p class="arca-body-lg arca-text-grey-600">
            Ulcerative colitis treatment has evolved from a limited anti-TNF landscape to an era of expanding mechanism diversity with JAK inhibitors, S1P modulators, anti-integrins, and anti-IL23 agents. Each class carries distinct systemic versus gut-selective safety trade-offs, and the ORAL Surveillance trial data has reshaped cardiovascular and malignancy risk assessment across the entire JAK inhibitor class, demanding disease-specific BRA frameworks.
          </p>
        </div>

        <div data-animate-stagger style="display: grid; grid-template-columns: repeat(3, 1fr); gap: 24px;">
          <div class="arca-card" data-animate="slide-up">
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-3);">JAK Inhibitor MACE/VTE/Malignancy Risk</h3>
            <p class="arca-body-sm arca-text-grey-600">
              The tofacitinib ORAL Surveillance trial demonstrated increased MACE, VTE, malignancy, and serious infection risk in RA patients &ge;50 years with cardiovascular risk factors, prompting a class-wide boxed warning. BRA for UC must contextualize this signal for the younger, lower-cardiovascular-risk IBD population. The platform models whether the ORAL Surveillance findings translate to UC populations and differentiates risk across JAK selectivity profiles (pan-JAK tofacitinib vs. JAK1-selective upadacitinib).
            </p>
          </div>
          <div class="arca-card" data-animate="slide-up">
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-3);">S1P Modulator &amp; Infection Risk</h3>
            <p class="arca-body-sm arca-text-grey-600">
              Ozanimod modulates sphingosine-1-phosphate receptors to sequester lymphocytes in lymph nodes, creating theoretical progressive multifocal leukoencephalopathy (PML) risk from the fingolimod precedent in multiple sclerosis. BRA must also address cardiac conduction effects (first-dose bradycardia), macular edema, hepatotoxicity, and the lymphopenia recovery timeline upon discontinuation&mdash;a critical consideration for patients requiring subsequent immunosuppressive therapy or surgery.
            </p>
          </div>
          <div class="arca-card" data-animate="slide-up">
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-3);">Colectomy as a Safety Endpoint</h3>
            <p class="arca-body-sm arca-text-grey-600">
              Unlike many chronic diseases, UC carries the irreversible safety endpoint of colectomy. BRA must model colectomy avoidance as a benefit alongside traditional efficacy endpoints (clinical remission, endoscopic improvement), while accounting for the safety risks of delaying necessary surgery with successive medical therapies. Anti-TNF failure rates, acute severe colitis rescue therapy outcomes, and timing of surgical intervention all factor into the benefit-risk equation.
            </p>
          </div>
        </div>
      </div>
    </section>

    <!-- ARCASCIENCE APPROACH -->
    <div class="arca-section-divider" aria-hidden="true"></div>

    <section class="arca-bg-grey-50 arca-bg-dots" style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="text-align: center; margin-bottom: var(--space-8);">
          <p class="arca-section-label">Platform Capabilities</p>
          <h2 class="arca-display-sm" style="margin-bottom: var(--space-4);">How ArcaScience Addresses Ulcerative Colitis BRA</h2>
          <p class="arca-body-lg arca-text-grey-600" style="max-width: 680px; margin: 0 auto;">
            Our platform integrates UC mechanism-specific data, cardiovascular risk contextualization models for JAK inhibitors, and regulatory templates aligned with GI submission requirements including post-ORAL Surveillance labeling considerations.
          </p>
        </div>

        <div data-animate-stagger style="display: grid; grid-template-columns: repeat(3, 1fr); gap: 24px;">
          <div class="arca-card arca-card-colored-top is-data" data-animate="slide-up">
            <span class="arca-module-tag is-data">Data Intelligence</span>
            <h3 class="arca-heading-2" style="margin: var(--space-4) 0 var(--space-3);">UC Data Coverage</h3>
            <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-5);">
              1,600+ UC clinical trials including OCTAVE, U-ACHIEVE/U-ACCOMPLISH, TRUE NORTH, GEMINI, UNIFI, ACT, PURSUIT, and LUCENT datasets. Adverse event data covering tofacitinib MACE/VTE (ORAL Surveillance), upadacitinib herpes zoster and hepatotoxicity, ozanimod cardiac conduction, vedolizumab PML theoretical risk, and anti-TNF opportunistic infections across all disease severity strata.
            </p>
            <a href="/platform-data-intelligence" class="arca-btn-tertiary">Explore Data Engine <span class="arca-arrow">&rarr;</span></a>
          </div>

          <div class="arca-card arca-card-colored-top is-analytics" data-animate="slide-up">
            <span class="arca-module-tag is-analytics">Decision Intelligence</span>
            <h3 class="arca-heading-2" style="margin: var(--space-4) 0 var(--space-3);">Mechanism-Specific AI Models</h3>
            <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-5);">
              AI models for JAK inhibitor cardiovascular risk contextualization across UC versus RA populations (adjusting for age, CV risk factors, and disease-specific inflammation), S1P modulator lymphocyte recovery modeling, anti-TNF immunogenicity prediction, and colectomy risk scoring across treatment sequences. BRAT framework application with UC-specific regulatory precedent including FDA GI advisory committee deliberations on JAK inhibitor class warnings.
            </p>
            <a href="/platform-ai-models" class="arca-btn-tertiary">Explore AI Models <span class="arca-arrow">&rarr;</span></a>
          </div>

          <div class="arca-card arca-card-colored-top is-output" data-animate="slide-up">
            <span class="arca-module-tag is-output">Automated Outputs</span>
            <h3 class="arca-heading-2" style="margin: var(--space-4) 0 var(--space-3);">UC Regulatory Outputs</h3>
            <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-5);">
              PSURs with MACE/VTE signal deep-dives contextualized for IBD populations, RMPs with cardiovascular monitoring protocols for JAK inhibitors and cardiac conduction surveillance for S1P modulators, CTD 2.5 with clinical remission, endoscopic improvement, and colectomy-free survival endpoint summaries, and HEOR reports supporting NICE, G-BA, and CADTH submissions for advanced UC therapies.
            </p>
            <a href="/platform-outputs" class="arca-btn-tertiary">Explore Outputs <span class="arca-arrow">&rarr;</span></a>
          </div>
        </div>
      </div>
    </section>

    <!-- KEY METRICS -->
    <section class="arca-bg-blue-50 arca-bg-mesh" style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="text-align: center; margin-bottom: var(--space-8);">
          <p class="arca-section-label">Ulcerative Colitis Intelligence</p>
          <h2 class="arca-display-sm">Platform Performance in Ulcerative Colitis</h2>
        </div>
        <div style="display: grid; grid-template-columns: repeat(4, 1fr); gap: 32px; text-align: center;">
          <div>
            <span class="arca-stat-lg" style="color: var(--teal-600);" data-countup="7800000000" data-countup-suffix="+">7,800,000,000+</span>
            <p class="arca-caption arca-text-grey-600">UC adverse event data points</p>
          </div>
          <div>
            <span class="arca-stat-lg" style="color: var(--teal-600);" data-countup="50" data-countup-suffix="%">50%</span>
            <p class="arca-caption arca-text-grey-600">Faster cardiovascular risk contextualization</p>
          </div>
          <div>
            <span class="arca-stat-lg" style="color: var(--teal-600);" data-countup="7">7</span>
            <p class="arca-caption arca-text-grey-600">Mechanism classes modeled</p>
          </div>
          <div>
            <span class="arca-stat-lg" style="color: var(--teal-600);" data-countup="9">9</span>
            <p class="arca-caption arca-text-grey-600">UC submissions supported</p>
          </div>
        </div>
      </div>
    </section>

    <!-- CASE EVIDENCE -->
    <section style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 64px; align-items: center;">
          <div>
            <p class="arca-section-label">Case Evidence &mdash; Ulcerative Colitis</p>
            <h2 class="arca-heading-1" style="margin-bottom: var(--space-5);">JAK Inhibitor Cardiovascular Risk Modeling Across UC vs. RA Populations</h2>
            <div style="margin-bottom: var(--space-5);">
              <h3 class="arca-heading-4" style="margin-bottom: var(--space-2); color: var(--teal-600);">Challenge</h3>
              <p class="arca-body-sm arca-text-grey-600">Following the ORAL Surveillance trial results in RA, a pharma company developing a JAK1-selective inhibitor for UC needed to model whether the cardiovascular, thromboembolic, and malignancy signals observed in the older RA population with pre-existing cardiovascular risk factors would translate to the younger, lower-cardiovascular-risk UC population. Regulators required disease-specific contextualization of the class-wide boxed warning.</p>
            </div>
            <div style="margin-bottom: var(--space-5);">
              <h3 class="arca-heading-4" style="margin-bottom: var(--space-2); color: var(--teal-600);">Result</h3>
              <p class="arca-body-sm arca-text-grey-600">ArcaScience deployed comparative population risk models adjusting for age distribution, baseline cardiovascular risk, inflammatory burden, and JAK selectivity differences. The analysis quantified the absolute risk difference for MACE and VTE in UC versus RA populations, demonstrating substantially lower absolute cardiovascular event rates in the younger UC population. This disease-contextualized BRA supported a differentiated label and informed prescribing guidance that reflected UC-specific rather than RA-extrapolated risk.</p>
            </div>
            <div style="display: grid; grid-template-columns: repeat(2, 1fr); gap: 24px; margin-bottom: var(--space-6);">
              <div>
                <span class="arca-stat-sm" style="color: var(--teal-600);" data-countup="3.1" data-countup-suffix="x">3.1x</span>
                <p class="arca-caption arca-text-grey-600">Faster population-adjusted risk analysis</p>
              </div>
              <div>
                <span class="arca-stat-sm" style="color: var(--teal-600);" data-countup="50" data-countup-suffix="%">50%</span>
                <p class="arca-caption arca-text-grey-600">Reduction in risk extrapolation uncertainty</p>
              </div>
            </div>
            <a href="/evidence-case-studies-hub" class="arca-btn-tertiary">View All Case Studies <span class="arca-arrow">&rarr;</span></a>
          </div>

          <div class="arca-testimonial" style="text-align: left;">
            <div class="arca-testimonial-quote" style="padding-left: 24px; border-left: 3px solid var(--blue-400);">
              The ORAL Surveillance findings created significant regulatory headwinds for our UC JAK inhibitor program. ArcaScience's population-adjusted cardiovascular risk modeling provided the quantitative evidence we needed to demonstrate that the absolute risk in our UC population was fundamentally different from the RA population studied in ORAL Surveillance. This directly informed our label negotiations with both FDA and EMA.
            </div>
            <div class="arca-testimonial-attribution" style="margin-top: var(--space-5);">
              <p class="arca-body-md" style="font-weight: 600;">SVP, Global Regulatory Affairs</p>
              <p class="arca-body-sm arca-text-grey-600">Mid-Size Biopharma Company</p>
            </div>
          </div>
        </div>
      </div>
    </section>

    <!-- FAQ ACCORDION -->
    <div class="arca-section-divider" aria-hidden="true"></div>

    <section class="arca-bg-teal-100 arca-bg-rings" style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="max-width: 720px; margin: 0 auto 48px; text-align: center;">
          <p class="arca-section-label">Frequently Asked Questions</p>
          <h2 class="arca-display-sm">Ulcerative Colitis Benefit-Risk Analysis</h2>
        </div>
        <div style="max-width: 820px; margin: 0 auto;">
          <div data-accordion="group">
            <div data-accordion-item style="border-bottom: 1px solid var(--grey-200);">
              <button data-accordion-trigger aria-expanded="false" style="width: 100%; text-align: left; padding: var(--space-5) 0; display: flex; justify-content: space-between; align-items: center; background: none; border: none; cursor: pointer;">
                <h3 class="arca-heading-3">How does ArcaScience contextualize the JAK inhibitor class warning for IBD versus RA populations?</h3>
                <svg data-accordion-icon width="16" height="16" viewBox="0 0 16 16" fill="none" style="flex-shrink: 0;"><path d="M4 6l4 4 4-4" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg>
              </button>
              <div data-accordion-content aria-hidden="true" style="max-height: 0; overflow: hidden; transition: max-height 300ms ease-out;">
                <div style="padding: 0 0 var(--space-5);"><p class="arca-body-sm arca-text-grey-600">The ORAL Surveillance boxed warning was derived from RA patients aged &ge;50 with at least one cardiovascular risk factor. UC patients are typically younger (median age at diagnosis 30&ndash;40 years) with lower baseline cardiovascular risk. ArcaScience models the absolute risk difference by adjusting for age distribution, baseline CV risk factor prevalence, inflammatory burden (which itself contributes to thrombosis in IBD), and JAK selectivity. We integrate OCTAVE long-term extension data, U-ACCOMPLISH cardiovascular event rates, and real-world IBD registries to provide UC-specific absolute risk estimates rather than extrapolated relative risk from the RA population.</p></div>
              </div>
            </div>
            <div data-accordion-item style="border-bottom: 1px solid var(--grey-200);">
              <button data-accordion-trigger aria-expanded="false" style="width: 100%; text-align: left; padding: var(--space-5) 0; display: flex; justify-content: space-between; align-items: center; background: none; border: none; cursor: pointer;">
                <h3 class="arca-heading-3">How does the platform model biologic-to-small-molecule switching safety?</h3>
                <svg data-accordion-icon width="16" height="16" viewBox="0 0 16 16" fill="none" style="flex-shrink: 0;"><path d="M4 6l4 4 4-4" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg>
              </button>
              <div data-accordion-content aria-hidden="true" style="max-height: 0; overflow: hidden; transition: max-height 300ms ease-out;">
                <div style="padding: 0 0 var(--space-5);"><p class="arca-body-sm arca-text-grey-600">Switching from biologics (anti-TNF, vedolizumab) to small molecules (tofacitinib, upadacitinib, ozanimod) is increasingly common in UC as patients cycle through therapies. ArcaScience models the washout period safety considerations including overlapping immunosuppression risk, disease flare during transition, and the immunogenicity implications of prior biologic exposure on subsequent therapy response. For patients switching from anti-TNF to JAK inhibitors, the platform accounts for residual anti-TNF drug levels and their interaction with JAK inhibitor immune modulation. This is particularly relevant for acute switches where washout periods are compressed due to active disease.</p></div>
              </div>
            </div>
            <div data-accordion-item style="border-bottom: 1px solid var(--grey-200);">
              <button data-accordion-trigger aria-expanded="false" style="width: 100%; text-align: left; padding: var(--space-5) 0; display: flex; justify-content: space-between; align-items: center; background: none; border: none; cursor: pointer;">
                <h3 class="arca-heading-3">Does the platform cover acute severe ulcerative colitis management BRA?</h3>
                <svg data-accordion-icon width="16" height="16" viewBox="0 0 16 16" fill="none" style="flex-shrink: 0;"><path d="M4 6l4 4 4-4" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg>
              </button>
              <div data-accordion-content aria-hidden="true" style="max-height: 0; overflow: hidden; transition: max-height 300ms ease-out;">
                <div style="padding: 0 0 var(--space-5);"><p class="arca-body-sm arca-text-grey-600">Yes. Acute severe UC (ASUC) is a medical emergency where BRA must balance rapid rescue therapy against surgical timing. ArcaScience models the benefit-risk of IV corticosteroid rescue, cyclosporine versus infliximab second-line rescue, and the emerging role of tofacitinib as rapid-acting rescue therapy. The platform integrates Travis criteria, Oxford ASUC scoring, and surgical complication rates for delayed versus early colectomy. Critically, the BRA accounts for the risk of medical over-treatment delaying necessary surgery, which increases post-operative morbidity and mortality.</p></div>
              </div>
            </div>
            <div data-accordion-item style="border-bottom: 1px solid var(--grey-200);">
              <button data-accordion-trigger aria-expanded="false" style="width: 100%; text-align: left; padding: var(--space-5) 0; display: flex; justify-content: space-between; align-items: center; background: none; border: none; cursor: pointer;">
                <h3 class="arca-heading-3">How does ArcaScience handle pregnancy planning BRA for UC patients?</h3>
                <svg data-accordion-icon width="16" height="16" viewBox="0 0 16 16" fill="none" style="flex-shrink: 0;"><path d="M4 6l4 4 4-4" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg>
              </button>
              <div data-accordion-content aria-hidden="true" style="max-height: 0; overflow: hidden; transition: max-height 300ms ease-out;">
                <div style="padding: 0 0 var(--space-5);"><p class="arca-body-sm arca-text-grey-600">Pregnancy planning is a critical BRA consideration in UC given the young patient population. ArcaScience models the reproductive safety profiles across all UC therapy classes. Anti-TNF agents (infliximab, golimumab) have extensive pregnancy safety data and are generally continued through pregnancy. In contrast, tofacitinib and upadacitinib are teratogenic (FDA pregnancy category X equivalent) requiring washout before conception. Ozanimod requires a 3-month washout due to prolonged lymphocyte recovery. Our platform models the disease flare risk during mandatory washout periods, optimal therapy transition strategies for conception planning, and the benefit-risk of continuing vedolizumab (pregnancy data reassuring but limited) versus switching to anti-TNF before conception.</p></div>
              </div>
            </div>
            <div data-accordion-item>
              <button data-accordion-trigger aria-expanded="false" style="width: 100%; text-align: left; padding: var(--space-5) 0; display: flex; justify-content: space-between; align-items: center; background: none; border: none; cursor: pointer;">
                <h3 class="arca-heading-3">How does the platform compare maintenance versus step-up strategy safety?</h3>
                <svg data-accordion-icon width="16" height="16" viewBox="0 0 16 16" fill="none" style="flex-shrink: 0;"><path d="M4 6l4 4 4-4" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg>
              </button>
              <div data-accordion-content aria-hidden="true" style="max-height: 0; overflow: hidden; transition: max-height 300ms ease-out;">
                <div style="padding: 0 0 var(--space-5);"><p class="arca-body-sm arca-text-grey-600">The traditional step-up approach (5-ASA to immunomodulators to biologics) versus early aggressive therapy (top-down) represents a fundamental BRA question in UC. ArcaScience models cumulative safety exposure across both strategies, including the long-term immunomodulator risks (lymphoma with thiopurines, hepatosplenic T-cell lymphoma with combination therapy), progressive disease damage from delayed effective therapy, and the potential to de-escalate after achieving deep remission. The platform integrates CALM trial methodology with UC-specific data to quantify whether early intensive therapy's short-term safety burden is offset by reduced long-term colectomy rates and cumulative steroid exposure.</p></div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </section>

    <!-- CTA -->
    <section class="arca-cta-section" data-animate style="position: relative; overflow: hidden;">
      <div style="position: absolute; top: -60px; left: -60px; width: 300px; height: 300px; background: radial-gradient(circle, rgba(255,255,255,0.08) 0%, transparent 70%); border-radius: 50%; filter: blur(40px); pointer-events: none; animation: as-float 7s ease-in-out infinite; z-index: 0;"></div>
      <div style="position: absolute; bottom: -40px; right: -40px; width: 250px; height: 250px; background: radial-gradient(circle, rgba(255,255,255,0.06) 0%, transparent 70%); border-radius: 50%; filter: blur(40px); pointer-events: none; animation: as-float 9s ease-in-out infinite reverse; z-index: 0;"></div>
      <div style="position: relative; z-index: 1; max-width: 680px; margin: 0 auto; padding: 0 24px;">
        <h2 class="arca-heading-1" style="margin-bottom: var(--space-5);">See ArcaScience Applied to Ulcerative Colitis</h2>
        <p class="arca-body-lg" style="margin-bottom: var(--space-7);">Request a demonstration of ArcaScience's platform configured for ulcerative colitis benefit-risk analysis. Our gastroenterology scientists will walk through mechanism-specific data coverage, cardiovascular risk contextualization models, colectomy avoidance scoring, and regulatory output examples.</p>
        <div style="display: flex; gap: 16px; justify-content: center; flex-wrap: wrap;">
          <a href="/contact?disease=ulcerative-colitis" class="arca-btn-primary-inverted">Request UC Briefing</a>
          <a href="/platform-overview" class="arca-btn-secondary" style="border-color: rgba(255,255,255,0.3); color: var(--white);">Explore the Platform <span class="arca-arrow">&rarr;</span></a>
        </div>
      </div>
    </section>

  </main>

    <!-- RELATED DISEASES -->
    <section class="arca-bg-grey-50" style="padding: var(--space-7) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="text-align: center; margin-bottom: var(--space-6);">
          <p class="arca-section-label">Explore More</p>
          <h2 class="arca-heading-2" style="margin-bottom: var(--space-3);">
            Related Gastroenterology Disease Pages
          </h2>
        </div>
        <div style="display: flex; flex-wrap: wrap; gap: 12px; justify-content: center;" data-animate-stagger>
          <a href="/ta-gastroenterology" class="arca-card" style="text-decoration: none; color: inherit; padding: var(--space-3) var(--space-5); text-align: center;" data-animate="slide-up">
            <span class="arca-heading-4" style="display: block; margin-bottom: 4px;">&larr; All Gastroenterology</span>
            <span class="arca-body-sm arca-text-grey-500">Back to overview</span>
          </a>
          <a href="/disease-crohns-disease" class="arca-card" style="text-decoration: none; color: inherit; padding: var(--space-3) var(--space-5); text-align: center;" data-animate="slide-up">
            <span class="arca-heading-4" style="display: block; margin-bottom: 4px;">Crohnâ€™s Disease</span>
            <span class="arca-body-sm arca-text-grey-500">View BRA &rarr;</span>
          </a>
        </div>
      </div>
    </section>

  <!-- FOOTER -->
  <footer class="arca-bg-blue-900" style="padding: var(--space-9) 0 var(--space-7);">
    <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
      <div style="display: grid; grid-template-columns: 2fr 1fr 1fr 1fr 1fr; gap: 48px;">
        <div>
          <img src="/images/arcascience-logo-white.svg" alt="ArcaScience" height="28" style="margin-bottom: var(--space-5);">
          <p class="arca-body-sm" style="color: rgba(255,255,255,0.65); max-width: 280px;">AI-driven benefit-risk analysis for pharmaceutical development. Founded 2018.</p>
        </div>
        <div>
          <p class="arca-label" style="color: rgba(255,255,255,0.45); margin-bottom: var(--space-4);">Platform</p>
          <nav style="display: flex; flex-direction: column; gap: 12px;">
            <a href="/platform-overview" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Overview</a>
            <a href="/platform-data-intelligence" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Data Intelligence</a>
            <a href="/platform-ai-models" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Decision Intelligence</a>
            <a href="/platform-outputs" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Regulatory Outputs</a>
            <a href="/security-compliance" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Security & Compliance</a>
          </nav>
        </div>
        <div>
          <p class="arca-label" style="color: rgba(255,255,255,0.45); margin-bottom: var(--space-4);">Solutions</p>
          <nav style="display: flex; flex-direction: column; gap: 12px;">
            <a href="/solution-therapeutic-area" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Therapeutic Areas</a>
            <a href="/ta-oncology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Oncology</a>
            <a href="/ta-neurology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Neurology</a>
            <a href="/ta-immunology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Immunology</a>
            <a href="/ta-cardiology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Cardiology</a>
            <a href="/ta-respiratory" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Respiratory</a>
            <a href="/ta-rare-diseases" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Rare Diseases</a>
            <a href="/ta-hematology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Hematology</a>
            <a href="/ta-dermatology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Dermatology</a>
            <a href="/solution-early-development" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Early Development</a>
            <a href="/solution-late-development" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Late Development</a>
          </nav>
        </div>
        <div>
          <p class="arca-label" style="color: rgba(255,255,255,0.45); margin-bottom: var(--space-4);">Company</p>
          <nav style="display: flex; flex-direction: column; gap: 12px;">
            <a href="/about" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">About</a>
            <a href="/leadership" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Team</a>
            <a href="/careers" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Careers</a>
            <a href="/about" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">News</a>
            <a href="/contact" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Contact</a>
          </nav>
        </div>
        <div>
          <p class="arca-label" style="color: rgba(255,255,255,0.45); margin-bottom: var(--space-4);">Resources</p>
          <nav style="display: flex; flex-direction: column; gap: 12px;">
            <a href="/evidence-case-studies-hub" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Case Studies</a>
            <a href="/resources-whitepapers" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Whitepapers</a>
            <a href="/resources" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Blog</a>
            <a href="/resources" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Documentation</a>
          </nav>
        </div>
      </div>
      <div style="margin-top: var(--space-8); padding-top: var(--space-5); border-top: 1px solid rgba(255,255,255,0.1); display: flex; justify-content: space-between; align-items: center;">
        <p class="arca-caption" style="color: rgba(255,255,255,0.45);">&copy; 2026 ArcaScience. All rights reserved.</p>
        <div style="display: flex; gap: 24px;">
          <a href="/legal-privacy" style="color: rgba(255,255,255,0.45); text-decoration: none; font-size: 0.75rem;">Privacy</a>
          <a href="/legal-terms" style="color: rgba(255,255,255,0.45); text-decoration: none; font-size: 0.75rem;">Terms</a>
          <a href="/legal-cookies" style="color: rgba(255,255,255,0.45); text-decoration: none; font-size: 0.75rem;">Cookies</a>
          <a href="/legal-accessibility" style="color: rgba(255,255,255,0.45); text-decoration: none; font-size: 0.75rem;">Accessibility</a>
        </div>
      </div>
    </div>
  </footer>

  <button data-back-to-top aria-label="Back to top">
    <svg width="16" height="16" viewBox="0 0 16 16" fill="none"><path d="M8 12V4M4 7l4-4 4 4" stroke="currentColor" stroke-width="1.5" stroke-linecap="round"/></svg>
  </button>

  <script src="/dist/arcascience-global.min.js" defer></script>
  <script src="/dist/arcascience-countup.min.js" defer></script>
  <script>
    document.addEventListener('DOMContentLoaded', function() {
      if (window.ArcaScience) ArcaScience.init();
      if (window.ArcaScienceCountUp) ArcaScienceCountUp.init({ selector: '[data-countup]' });
    });
  </script>
</body>
</html>